These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

391 related articles for article (PubMed ID: 20682320)

  • 1. Budesonide is effective in adolescent and adult patients with active eosinophilic esophagitis.
    Straumann A; Conus S; Degen L; Felder S; Kummer M; Engel H; Bussmann C; Beglinger C; Schoepfer A; Simon HU
    Gastroenterology; 2010 Nov; 139(5):1526-37, 1537.e1. PubMed ID: 20682320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral viscous budesonide is effective in children with eosinophilic esophagitis in a randomized, placebo-controlled trial.
    Dohil R; Newbury R; Fox L; Bastian J; Aceves S
    Gastroenterology; 2010 Aug; 139(2):418-29. PubMed ID: 20457157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral viscous budesonide: a potential new therapy for eosinophilic esophagitis in children.
    Aceves SS; Bastian JF; Newbury RO; Dohil R
    Am J Gastroenterol; 2007 Oct; 102(10):2271-9; quiz 2280. PubMed ID: 17581266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral budesonide for maintenance treatment of collagenous colitis: a randomized, double-blind, placebo-controlled trial.
    Miehlke S; Madisch A; Bethke B; Morgner A; Kuhlisch E; Henker C; Vogel G; Andersen M; Meier E; Baretton G; Stolte M
    Gastroenterology; 2008 Nov; 135(5):1510-6. PubMed ID: 18926826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term budesonide maintenance treatment is partially effective for patients with eosinophilic esophagitis.
    Straumann A; Conus S; Degen L; Frei C; Bussmann C; Beglinger C; Schoepfer A; Simon HU
    Clin Gastroenterol Hepatol; 2011 May; 9(5):400-9.e1. PubMed ID: 21277394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized, double-blind, placebo-controlled trial of fluticasone propionate for pediatric eosinophilic esophagitis.
    Konikoff MR; Noel RJ; Blanchard C; Kirby C; Jameson SC; Buckmeier BK; Akers R; Cohen MB; Collins MH; Assa'ad AH; Aceves SS; Putnam PE; Rothenberg ME
    Gastroenterology; 2006 Nov; 131(5):1381-91. PubMed ID: 17101314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topical viscous budesonide suspension for treatment of eosinophilic esophagitis.
    Aceves SS; Dohil R; Newbury RO; Bastian JF
    J Allergy Clin Immunol; 2005 Sep; 116(3):705-6. PubMed ID: 16159647
    [No Abstract]   [Full Text] [Related]  

  • 8. Budesonide is effective in treating lymphocytic colitis: a randomized double-blind placebo-controlled study.
    Miehlke S; Madisch A; Karimi D; Wonschik S; Kuhlisch E; Beckmann R; Morgner A; Mueller R; Greinwald R; Seitz G; Baretton G; Stolte M
    Gastroenterology; 2009 Jun; 136(7):2092-100. PubMed ID: 19303012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment with high-dose proton pump inhibitors helps distinguish eosinophilic esophagitis from noneosinophilic esophagitis.
    Sayej WN; Patel R; Baker RD; Tron E; Baker SS
    J Pediatr Gastroenterol Nutr; 2009 Oct; 49(4):393-9. PubMed ID: 19633574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What's new in the diagnosis and therapy of eosinophilic esophagitis?
    Straumann A; Hruz P
    Curr Opin Gastroenterol; 2009 Jul; 25(4):366-71. PubMed ID: 19444097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical evaluation of the adult who has eosinophilic esophagitis.
    Straumann A
    Immunol Allergy Clin North Am; 2009 Feb; 29(1):11-8, vii. PubMed ID: 19141337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resolution of remodeling in eosinophilic esophagitis correlates with epithelial response to topical corticosteroids.
    Aceves SS; Newbury RO; Chen D; Mueller J; Dohil R; Hoffman H; Bastian JF; Broide DH
    Allergy; 2010 Jan; 65(1):109-16. PubMed ID: 19796194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histopathologic variability in children with eosinophilic esophagitis.
    Shah A; Kagalwalla AF; Gonsalves N; Melin-Aldana H; Li BU; Hirano I
    Am J Gastroenterol; 2009 Mar; 104(3):716-21. PubMed ID: 19209168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eosinophilic esophagitis.
    Shitrit AB; Reinus C; Zeides S; Braverman D
    Isr Med Assoc J; 2006 Aug; 8(8):587. PubMed ID: 16958256
    [No Abstract]   [Full Text] [Related]  

  • 15. Eosinophilic esophagitis: a 10-year experience in 381 children.
    Liacouras CA; Spergel JM; Ruchelli E; Verma R; Mascarenhas M; Semeao E; Flick J; Kelly J; Brown-Whitehorn T; Mamula P; Markowitz JE
    Clin Gastroenterol Hepatol; 2005 Dec; 3(12):1198-206. PubMed ID: 16361045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of Budesonide Orodispersible Tablets as Induction Therapy for Eosinophilic Esophagitis in a Randomized Placebo-Controlled Trial.
    Lucendo AJ; Miehlke S; Schlag C; Vieth M; von Arnim U; Molina-Infante J; Hartmann D; Bredenoord AJ; Ciriza de Los Rios C; Schubert S; Brückner S; Madisch A; Hayat J; Tack J; Attwood S; Mueller R; Greinwald R; Schoepfer A; Straumann A;
    Gastroenterology; 2019 Jul; 157(1):74-86.e15. PubMed ID: 30922997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of Pharmacologic Therapy for Eosinophilic Esophagitis: A Systematic Review and Network Meta-Analysis.
    Tomizawa Y; Melek J; Komaki Y; Kavitt RT; Sakuraba A
    J Clin Gastroenterol; 2018 Aug; 52(7):596-606. PubMed ID: 28787360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 3-yr-follow-up of topical corticosteroid treatment for eosinophilic esophagitis in adults.
    Helou EF; Simonson J; Arora AS
    Am J Gastroenterol; 2008 Sep; 103(9):2194-9. PubMed ID: 18637093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-IL-5 (mepolizumab) therapy for eosinophilic esophagitis.
    Stein ML; Collins MH; Villanueva JM; Kushner JP; Putnam PE; Buckmeier BK; Filipovich AH; Assa'ad AH; Rothenberg ME
    J Allergy Clin Immunol; 2006 Dec; 118(6):1312-9. PubMed ID: 17157662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Budesonide Oral Suspension Improves Symptomatic, Endoscopic, and Histologic Parameters Compared With Placebo in Patients With Eosinophilic Esophagitis.
    Dellon ES; Katzka DA; Collins MH; Hamdani M; Gupta SK; Hirano I;
    Gastroenterology; 2017 Mar; 152(4):776-786.e5. PubMed ID: 27889574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.